David M Brown MD FACS

Процитировано

	Все	Начиная с 2019 г.
Статистика цитирования	77715	29044
h-индекс	120	76
i10-индекс	557	280

6000

3000

1500

4500

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024322 410 330 409 460 486 469 573 471 511 492 560 510 515 510 507 475 483 429 518 503 572 853 1129 1390 1727 1991 2705 3089 3672 4172 4399 4337 4471 4474 4996 5315 4853 4749 4417

Общий доступ

Просмотреть все

95 статей

7 статей

доступно

недоступно

На основе финансирования

Соавторы

Charles Wykoff MD PhDRetina Consultants of Texas, Director of Research; Retina Consultants of America; Blanton EyeПодтвержден адрес электронной почты в домене retinaconsultantstexas.com
Eric ChenRetina Consultants of Texas, Houston Methodist HospitalПодтвержден адрес электронной почты в домене retinaconsultantstexas.com
Victor ChongClearside Biomedical IncПодтвержден адрес электронной почты в домене eretina.org
T Ciulla, TA Ciulla, Thomas CiullaChief Medical Officer, Viridian; Volunteer Clinical Professor, Indiana Univ Schl of MedicineПодтвержден адрес электронной почты в домене midwesteye.com
Dr. Rishi P. Singh, MDCenter for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland ClinicПодтвержден адрес электронной почты в домене ccf.org
Val C. Sheffield, M.D., Ph.D.Investigator, Howard Hughes Medical Institute, Professor of Pediatrics, University of IowaПодтвержден адрес электронной почты в домене uiowa.edu
Kang ZhangMacau University of Science and TechnologyПодтвержден адрес электронной почты в домене must.edu.mo

David M Brown MD FACS

Director of Research, Retina Consultants of Houston

Подтвержден адрес электронной почты в домене houstonretina.com - Главная страница

macular surgery diabetic retinopathy age-related macular degeneration


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Ranibizumab for neovascular age-related macular degeneration PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ... New England Journal of Medicine 355 (14), 1419-1431, 2006	7826*	2006
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration JS Heier, DM Brown, V Chong, JF Korobelnik, PK Kaiser, QD Nguyen, ... Ophthalmology 119 (12), 2537-2548, 2012	2753	2012
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE QD Nguyen, DM Brown, DM Marcus, DS Boyer, S Patel, L Feiner, ... Ophthalmology 119 (4), 789-801, 2012	1980	2012
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev Ophthalmology 116 (1), 57-65. e5, 2009	1766	2009
Structural-functional relationships in diabetic nephropathy. SM Mauer, MW Steffes, EN Ellis, DE Sutherland, DM Brown, FC Goetz The Journal of clinical investigation 74 (4), 1143-1155, 1984	1584	1984
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema DS Boyer, YH Yoon, R Belfort Jr, F Bandello, RK Maturi, AJ Augustin, ... Ophthalmology 121 (10), 1904-1914, 2014	1305	2014
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study PA Campochiaro, JS Heier, L Feiner, S Gray, N Saroj, AC Rundle, ... Ophthalmology 117 (6), 1102-1112. e1, 2010	1229	2010
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1 CD Regillo, DM Brown, P Abraham, H Yue, T Ianchulev, S Schneider, ... American journal of ophthalmology 145 (2), 239-248. e5, 2008	1142	2008
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study DM Brown, PA Campochiaro, RP Singh, Z Li, S Gray, N Saroj, AC Rundle, ... Ophthalmology 117 (6), 1124-1133. e1, 2010	1108	2010
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE DM Brown, QD Nguyen, DM Marcus, DS Boyer, S Patel, L Feiner, ... Ophthalmology 120 (10), 2013	1060	2013
Intravitreal aflibercept for diabetic macular edema JF Korobelnik, DV Do, U Schmidt-Erfurth, DS Boyer, FG Holz, JS Heier, ... Ophthalmology 121 (11), 2247-2254, 2014	1043	2014
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies U Schmidt-Erfurth, PK Kaiser, JF Korobelnik, DM Brown, V Chong, ... Ophthalmology 121 (1), 193-201, 2014	983	2014
Identification of novel genes in Arabidopsis involved in secondary cell wall formation using expression profiling and reverse genetics DM Brown, LAH Zeef, J Ellis, R Goodacre, SR Turner The Plant Cell 17 (8), 2281-2295, 2005	882	2005
HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration PU Dugel, A Koh, Y Ogura, GJ Jaffe, U Schmidt-Erfurth, DM Brown, ... Ophthalmology 127 (1), 72-84, 2020	871	2020
Measurements of , , and cross sections using initial state radiation events B Aubert, M Bona, D Boutigny, Y Karyotakis, JP Lees, V Poireau, ... Physical Review D—Particles, Fields, Gravitation, and Cosmology 77 (9), 092002, 2008	774*	2008
Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema Diabetic Retinopathy Clinical Research Network Ophthalmology 114 (3), 525-536, 2007	726	2007
Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies DM Brown, U Schmidt-Erfurth, DV Do, FG Holz, DS Boyer, E Midena, ... Ophthalmology 122 (10), 2044-2052, 2015	692	2015
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective … H Grundmann, C Glasner, B Albiger, DM Aanensen, CT Tomlinson, ... The Lancet infectious diseases 17 (2), 153-163, 2017	682	2017
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study PA Campochiaro, DM Brown, CC Awh, SY Lee, S Gray, N Saroj, ... Ophthalmology 118 (10), 2041-2049, 2011	675	2011
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema PA Campochiaro, DM Brown, A Pearson, S Chen, D Boyer, ... Ophthalmology 119 (10), 2125-2132, 2012	663	2012

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы